CPC outcome evaluation was performed at 6 months after a medical and neurological examination; in the same session, patients were subjected to a neuropsychological evaluation, the results of which were not considered for the following study.
APACHE: acute physiology and chronic health evaluation; CPC: cerebral performance category; CPR: cardiopulmonary resuscitation; ICU: intensive care unit; NSE: neuron-specific enolase; OHCA: out-of-hospital cardiac arrest; VF: ventricular fibrillation.
Five types of CPC were fabricated: a CPC control, CPC + 0.05% fibronectin (Fn), CPC + 0.1% Fn, CPC + 0.1% arginine glycine aspartate (RGD), and CPC + 0.1% Fn + 0.1% RGD.
This latter correlation offers an alternative to evaluation of CPC performance via the corroded area calculated from Cdl.
APACHE II, Acute Physiology and Chronic Health Evaluation II; CPC, cerebral performance category; CPR, cardiopulmonary resuscitation; ICU, intensive care unit; ROSC, return of spontaneous circulation.
The growth factor release ability and the osteogenic evaluation of PRP, CPC, and PRP/CPC testing groups with 5, 10, and 15 wt.% PRP were compared in vitro.
The evaluation of Chemical Protective Clothing (CPC) designs, design features, performance, and applications requires an understanding of the types of chemical protective clothing available for protection.
ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone, vasopressin; APACHE, Acute Physiology and Chronic Health Evaluation; BLS, basic life support; CPC, cerebral performance category (good CPC: 1 to 2, poor CPC: 3 to 5).
* P < 0.05 ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone, vasopressin; APACHE, Acute Physiology and Chronic Health Evaluation; BLS, basic life support; CPC, cerebral performance category (good CPC: 1 to 2, poor CPC: 3 to 5); DM, diabetes mellitus; HTN, hypertension; RAI, relative adrenal insufficiency; SOFA, The Sequential Organ Failure Assessment.
